Summary Small cell bronchial carcinoma (SCC) xenografts with differing sensitivity to cyclophosphamide (CY) were investigated using a variety of techniques. Two xenografts (HX78 and HX88) were relatively sensitive to CY, one xenograft (HX72) was inherently resistant to CY and a fourth xenograft (HX78Cy) was a CY induced resistant subline of HX78 and was unstable when maintained without CY exposure. Conventional light microscopy, cytology and electron microscopy examination of the xenografts revealed appearances consistent with SCC. An antikeratin antibody demonstrated the presence of keratin in the inherant and the induced resistant xenografts (and in the unstable revertant) but not in the two sensitive xenografts; the presence of keratin suggested squamous differentiation. Monolayer culture morphology of the sensitive HX78 and the unstable revertant was anchorage independent with the cells forming floating aggregates; the induced resistant subline of this xenograft (HX78Cy) showed, by contrast, flattened, angular adherent cells. PHCG production was detected in the monolayer culture supernatant of sensitive HX78 cells; the level of production of /HCG was increased in the induced resistant HX78Cy cells. Karyotype and flow cytometry studies were also performed. The morphological responses of small cell lung cancer to treatment are discussed.
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In a previous publication (Berman & Steel, 1984) , in vivo investigations on induced and inherent resistance in human small cell lung cancer (SCC) xenografts were described. Specimens from three patients were established in immune suppressed mice and the sensitivity of the xenografts to a variety of alkylating agents was determined using growth delay as the end-point. Clinical chemosensitivity data were available in two cases for comparison. In the first, the patient was found to have disease of low sensitivity and this was reflected in the response of the corresponding xenograft. The second patient, in contrast, was found to have relatively chemosensitive disease and again this was reflected in the xenograft response.
In one of the xenografts repeated treatment with cyclophosphamide (CY) led to induced resistance. The resistant line was about 8-fold less sensitive than the parent line but even after a year of repeated treatment, complete abolition of response was not achieved. When the CY resistant line was tested with a variety of other agents, a broad pattern of cross resistance was observed. It was also found that the CY resistant phenotype was unstable.
The investigations described here were designed to evaluate the biological basis of the observed drug resistance. 
Materials and methods

Xenografts
Tissue from three patients with small-cell lung cancer was used, as described previously (Berman & Steel. 1984) . The donor of HX72 (diagnosed from bronchoscopy specimens) had shown a partial response (PR) to cyclophosphamide (CY), CCNU and methotrexate (MTX) but then showed evidence of disease progression some 3 months after chemotherapy had been started. A tumour specimen was taken from a s.c. nodule after chemotherapy and established as a xenograft. The donor of HX88 showed a complete response to ifosphamide but later relapsed after 19 months. Further chemotherapy with mAMSA (4'-(9-Acridinylamino) methanesulfon-m-anisidide) and etoposide was tried without success. The xenograft specimen was taken from a supraclavicular fossa mass before any chemotherapy had been given. The reported previously (Shorthouse et al., 1980) . The methods of drug treatment, in vivo tumour measurement, and assessment of response using the growth delay end-point, have been described (Berman & Steel, 1984 (Gusterson et al., 1982) . Monolayer/suspension culture One ml cell suspensions, prepared mechanically, at dilutions of 104-106 cells ml-1 were introduced into 50 ml tissue culture flasks with 2 ml of culture medium. Alternatively dilute tumour pieces were employed. Flasks were gassed with 3% oxygen. After 3 days, 5 ml of culture medium was added and a week later a further 5 ml of culture medium was added, the flasks being gassed on each occasion.
/HCG production flHCG released into the medium of monolayer/suspension cultures was assayed by means of the radioimmune assay method of Shorthouse et al (1982) on material harvested at 2 weeks. This assay was kindly performed by Dr M.
Ellison and colleagues (Ludwig Institute, London).
Chromosome analysis Tumour cell suspensions, prepared mechanically, were incubated with colcemid 0.2 jIg ml -1 in saline at 370C for 45 min. They were then spun at The inherently resistant HX72 and the induced resistant HX78Cy stained strongly with the antikeratin antibody. In some areas the cells were slightly larger and arranged nests which were clearly delineated with the antibody suggesting the presence of squamous elements (Figure 1 ). These areas were not identifiable on the Haematoxylin and eosin-stained sections. The more sensitive HX88 and HX78, by contrast, stained weakly positive to essentially negative with this antibody. The sensitive HX78, after a single treatment with CY, was not associated with an alteration of CY response (Berman & Steel, 1984) . After a single CY treatment the staining of HX78 was indistinguishable from the untreated control. When HX78Cy was grown on for two passages without CY treatment, sensitivity to CY was found to return (Berman & Steel, 1984) . This revertant, HX78Cy-2 showed the majority of its cells to be positive. Positivity was also found in adenocarcinoma xenografts (HX70 and HX65) and most strongly of all in a squamous cell carcinoma xenograft (HX79).
Glandular elements Of the three SCC xenografts examined, none showed evidence of mucin production.
Neuroendocrine elements Three SCC xenografts were investigated, but only one, the inherently resistant HX72, was found to be positive. The induced resistant HX78Cy and its parent line, HX78, were both negative.
Electron microscopy EM appearances of HX78, HX78Cy and HX72 (HX88 not examined) were consistent with SCC and the characteristic dense core vesicles were evident in all specimens. Comparing HX78Cy with HX78, nucleoli were more prominent, cell process contained less glycogen and in general glycogen was less dense. Tonofilaments and desmosomes (squamous features) were unremarkable in both HX78Cy and HX72.
Cytology
Examination of centrifuge preparations of cell suspensions revealed that HX88, HX78, HX78Cy and HX72, all had appearances of typical SCC though in some preparations or parts of them, morphology was more in keeping with lymphoid cells.
Cell size analysis (Table I) showed that the mean cell diameter in HX78Cy was slightly reduced by comparison with HX78. Both, however, were somewhat larger than HX88 or HX72.
Monolayer/suspension culture morphology The appearances of HX78 and HX78Cy were found to be quite different in these cultures. HX78 cells remained typical of SCC grown in this manner, i.e. they were anchorage independent and formed floating aggregates. Only the occasional cell could be seen adherent to the dish. HX78Cy cells, by contrast, showed large numbers of cells adherent to the dish, with a flattened and angular appearance; far fewer cells formed floating aggregates. The revertant, HX78Cy-3 (3rd passage without treatment), had morphological features which had reverted to those of the parent line, i.e. there was loss of adherence.
JIHCG production ,BHCG production was found in HX78 cells, at a level of 1.6-2.4ngml-1 in the monolayer culture supernatant. HX78Cy, at a stage when it was approximately seven times more resistant to CY than the parent line, was found to produce some five times the amount of,HCG than HX78.
Chromosome analysis andflow cytometry All the xenografts contained human chromosomes. As shown in Table I (1981) , using light microscopy, as large cell carcinoma, squamous cell carcinoma or adenocarcinoma. Ultrastructural studies showed, however, all these tumours to contain numerous dense core granules; serotonin was identified in six and argyrophilic granules were demonstrated in 5 of 6 tested. These three features are usually associated with neurosecretory cells. Gusterson et al. (1982) identified keratin immunoreactive cells in all eight epidermoid carcinomas examined, but also in 6 out of 12 large cell carcinomas, 2 out of 6 adenocarcinomas and 2 out of 15 small cell carcinomas. Hence there may be heterogeneity of phenotypic expression in lung tumours not normally recognisable at the light microscopy level. Moreover, "local microenvironmental pressures" may result in differentiation towards different morphological cell types (McDowell et al., 1978 , Gusterson, 1984 ; and the concept of a distinct and different histogenesis for each of the light microscopy groups may be overstated.
Treatment itself may play a part in phenotypic lability. There have been a number of clinicopathological studies of chemotherapy treated patients where pretreatment diagnostic material has been compared with autopsy findings. The studies of Brereton et al. (1978) , Matthews (1979) and Abeloff & Eggleston (1981) have examined in this way a large number of patients initially diagnosed as having small cell lung cancer. At post-mortem the findings have been, in as many as 14-33% of cases, foci of various non-small cell elements in addition to the predominantly small cell component. In a smaller proportion of cases, 5.5-12.5%, there was no identifiable small cell cancer evident; these cases showed squamous cell carcinomas, adenocarcinomas and large cell carcinomas. Possible explanations were offered (1) Non-representative initial biopsy, (2) Selective eradication of the small-cell component of a mixed tumour with subsequent growth of the initially inconspicuous non-small component, (3) Cure of the small cell tumour with emergence of a second primary, (4) Alteration of cell differentiation of the small cell tumour.
The results reported here favour postulates (2) and/or (4). Much further investigation is necessary to elucidate the histological and drug sensitivity mechanisms; the present evidence encourages more detailed studies of histological processes in small cell lung cancers.
